Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 8/31/2023 | 8/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Revenue | $13,294 | $12,572 | $11,738 | $9,305 |
| % Growth | 5.7% | 7.1% | 26.1% | – |
| Cost of Goods Sold | $7,552 | $7,619 | $6,939 | $5,482 |
| Gross Profit | $5,743 | $4,953 | $4,799 | $3,823 |
| % Margin | 43.2% | 39.4% | 40.9% | 41.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $14,039 | $13,491 | $14,365 | $8,090 |
| SG&A Expenses | $14,056 | $13,506 | $14,385 | $8,097 |
| Sales & Mktg Exp. | $17 | $15 | $21 | $8 |
| Other Operating Expenses | $0 | $0 | $0 | $99 |
| Operating Expenses | $14,056 | $13,506 | $14,385 | $8,197 |
| Operating Income | -$8,314 | -$8,553 | -$9,586 | -$4,274 |
| % Margin | -62.5% | -68% | -81.7% | -45.9% |
| Other Income/Exp. Net | -$7,815 | -$4,716 | -$23,481 | -$197 |
| Pre-Tax Income | -$16,129 | -$13,269 | -$33,067 | -$4,471 |
| Tax Expense | $0 | $0 | -$22 | $0 |
| Net Income | -$16,129 | -$13,215 | -$32,849 | -$4,462 |
| % Margin | -121.3% | -105.1% | -279.9% | -48% |
| EPS | -0.9 | -1.3 | -11.28 | -1.8 |
| % Growth | 30.8% | 88.5% | -526.7% | – |
| EPS Diluted | -0.9 | -1.3 | -11.28 | -1.8 |
| Weighted Avg Shares Out | 18,032 | 10,166 | 2,912 | 2,477 |
| Weighted Avg Shares Out Dil | 18,032 | 10,166 | 2,912 | 2,477 |
| Supplemental Information | – | – | – | – |
| Interest Income | $203 | $9 | $169 | $46 |
| Interest Expense | -$652 | $5,118 | $7,568 | $165 |
| Depreciation & Amortization | $6,705 | $2,303 | $3,019 | $1,724 |
| EBITDA | -$10,076 | -$5,849 | -$22,480 | -$2,582 |
| % Margin | -75.8% | -46.5% | -191.5% | -27.7% |